Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 104

1.

Reproducibility of airway luminal size in asthma measured by HRCT.

Brown RH, Henderson RJ, Sugar EA, Holbrook JT, Wise RA.

J Appl Physiol (1985). 2017 Jul 13:jap.00307.2017. doi: 10.1152/japplphysiol.00307.2017. [Epub ahead of print]

PMID:
28705995
2.

Validity of the Asthma Control Test Questionnaire among Smoking Asthmatics.

Soler X, Holbrook JT, Gerald LB, Berry CE, Saams J, Henderson RJ, Sugar E, Wise RA, Ramsdell JW.

J Allergy Clin Immunol Pract. 2017 Jun 29. pii: S2213-2198(17)30371-9. doi: 10.1016/j.jaip.2017.05.010. [Epub ahead of print]

PMID:
28669892
3.

Longitudinal Vision-Related Quality of Life for Patients with Noninfectious Uveitis Treated with Fluocinolone Acetonide Implant or Systemic Corticosteroid Therapy.

Sugar EA, Venugopal V, Thorne JE, Frick KD, Holland GN, Wang RC, Almanzor R, Jabs DA, Holbrook JT; Multicenter Uveitis Steroid Treatment (MUST) Trial Research Group.

Ophthalmology. 2017 Jun 14. pii: S0161-6420(16)32265-5. doi: 10.1016/j.ophtha.2017.05.015. [Epub ahead of print]

PMID:
28624167
4.

Association Between Long-Lasting Intravitreous Fluocinolone Acetonide Implant vs Systemic Anti-inflammatory Therapy and Visual Acuity at 7 Years Among Patients With Intermediate, Posterior, or Panuveitis.

Writing Committee for the Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study Research Group, Kempen JH, Altaweel MM, Holbrook JT, Sugar EA, Thorne JE, Jabs DA.

JAMA. 2017 May 16;317(19):1993-2005. doi: 10.1001/jama.2017.5103.

PMID:
28477440
5.

Effect of intranasal corticosteroids on allergic airway disease in asthma.

Dixon AE, Castro M, Gerald LB, Holbrook JT, Henderson RJ, Casale TB, Irvin CG, Black K, Wise RA, Sugar EA; American Lung Association Airways Clinical Research Centers' Writing Committee.

J Allergy Clin Immunol Pract. 2017 Jul - Aug;5(4):1125-1128.e3. doi: 10.1016/j.jaip.2017.02.022. Epub 2017 Apr 7. No abstract available.

PMID:
28396113
6.

Correction: Lack of Effect of Oral Sulforaphane Administration on Nrf2 Expression in COPD: A Randomized, Double-Blind, Placebo Controlled Trial.

Wise RA, Holbrook JT, Criner G, Sethi S, Rayapudi S, Sudini KR, Sugar EA, Burke A, Thimmulappa R, Singh A, Talalay P, Fahey JW, Berenson CS, Jacobs MR, Biswal S; Broccoli Sprout Extract Trial Research Group.

PLoS One. 2017 Mar 28;12(3):e0175077. doi: 10.1371/journal.pone.0175077. eCollection 2017.

7.

Lack of Effect of Oral Sulforaphane Administration on Nrf2 Expression in COPD: A Randomized, Double-Blind, Placebo Controlled Trial.

Wise RA, Holbrook JT, Criner G, Sethi S, Rayapudi S, Sudini KR, Sugar EA, Burke A, Thimmulappa R, Singh A, Talalay P, Fahey JW, Berenson CS, Jacobs MR, Biswal S; Broccoli Sprout Extract Trial Research Group.

PLoS One. 2016 Nov 10;11(11):e0163716. doi: 10.1371/journal.pone.0163716. eCollection 2016. Erratum in: PLoS One. 2017 Mar 28;12 (3):e0175077.

8.

Measurement characteristics of the childhood Asthma-Control Test and a shortened, child-only version.

Bime C, Gerald JK, Wei CY, Holbrook JT, Teague WG, Wise RA, Gerald LB.

NPJ Prim Care Respir Med. 2016 Oct 20;26:16075. doi: 10.1038/npjpcrm.2016.75.

9.

Effect of Continuous Positive Airway Pressure on Airway Reactivity in Asthma. A Randomized, Sham-controlled Clinical Trial.

Holbrook JT, Sugar EA, Brown RH, Drye LT, Irvin CG, Schwartz AR, Tepper RS, Wise RA, Yasin RZ, Busk MF; American Lung Association Airways Clinical Research Centers.

Ann Am Thorac Soc. 2016 Nov;13(11):1940-1950.

PMID:
27398992
10.

Gastro-oesophageal reflux and worse asthma control in obese children: a case of symptom misattribution?

Lang JE, Hossain J, Holbrook JT, Teague WG, Gold BD, Wise RA, Lima JJ.

Thorax. 2016 Mar;71(3):238-46. doi: 10.1136/thoraxjnl-2015-207662. Epub 2016 Feb 1.

PMID:
26834184
11.

Using a patient-centered approach to benefit-harm assessment in treatment decision-making: a case study in uveitis.

Yu T, Holbrook JT, Thorne JE, Puhan MA.

Pharmacoepidemiol Drug Saf. 2016 Apr;25(4):363-71. doi: 10.1002/pds.3959. Epub 2016 Jan 22.

12.

Dissociations of the Fluocinolone Acetonide Implant: The Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study.

Holbrook JT, Sugar EA, Burke AE, Vitale AT, Thorne JE, Davis JL, Jabs DA; Multicenter Uveitis Steroid Treatment (MUST) Trial Research Group.

Am J Ophthalmol. 2016 Apr;164:29-36. doi: 10.1016/j.ajo.2015.12.028. Epub 2015 Dec 31.

13.

Predictors of asthma exacerbation among patients with poorly controlled asthma despite inhaled corticosteroid treatment.

Quezada W, Kwak ES, Reibman J, Rogers L, Mastronarde J, Teague WG, Wei C, Holbrook JT, DiMango E.

Ann Allergy Asthma Immunol. 2016 Feb;116(2):112-7. doi: 10.1016/j.anai.2015.11.011. Epub 2015 Dec 19.

14.

Use of surrogate outcomes in US FDA drug approvals, 2003-2012: a survey.

Yu T, Hsu YJ, Fain KM, Boyd CM, Holbrook JT, Puhan MA.

BMJ Open. 2015 Nov 27;5(11):e007960. doi: 10.1136/bmjopen-2015-007960.

15.

Outcome Preferences in Patients With Noninfectious Uveitis: Results of a Best-Worst Scaling Study.

Yu T, Holbrook JT, Thorne JE, Flynn TN, Van Natta ML, Puhan MA.

Invest Ophthalmol Vis Sci. 2015 Oct;56(11):6864-72. doi: 10.1167/iovs.15-16705.

16.

Cataract Surgery Outcomes in Uveitis: The Multicenter Uveitis Steroid Treatment Trial.

Sen HN, Abreu FM, Louis TA, Sugar EA, Altaweel MM, Elner SG, Holbrook JT, Jabs DA, Kim RY, Kempen JH; Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study Research Group.

Ophthalmology. 2016 Jan;123(1):183-90. doi: 10.1016/j.ophtha.2015.09.022. Epub 2015 Oct 20.

17.

Factors Predicting Visual Acuity Outcome in Intermediate, Posterior, and Panuveitis: The Multicenter Uveitis Steroid Treatment (MUST) Trial.

Kempen JH, Van Natta ML, Altaweel MM, Dunn JP, Jabs DA, Lightman SL, Thorne JE, Holbrook JT; Multicenter Uveitis Steroid Treatment (MUST) Trial Research Group.

Am J Ophthalmol. 2015 Dec;160(6):1133-1141.e9. doi: 10.1016/j.ajo.2015.09.017. Epub 2015 Sep 18.

18.

Outcome of Treatment of Uveitic Macular Edema: The Multicenter Uveitis Steroid Treatment Trial 2-Year Results.

Tomkins-Netzer O, Lightman S, Drye L, Kempen J, Holland GN, Rao NA, Stawell RJ, Vitale A, Jabs DA; Multicenter Uveitis Steroid Treatment Trial Research Group.

Ophthalmology. 2015 Nov;122(11):2351-9. doi: 10.1016/j.ophtha.2015.07.036. Epub 2015 Sep 7.

19.

Albuterol Overuse: A Marker of Psychological Distress?

Gerald JK, Carr TF, Wei CY, Holbrook JT, Gerald LB.

J Allergy Clin Immunol Pract. 2015 Nov-Dec;3(6):957-62. doi: 10.1016/j.jaip.2015.06.021. Epub 2015 Sep 1.

20.

Supplemental Content

Loading ...
Support Center